市场调查报告书
商品编码
1471368
PTA 球囊导管市场:按材料、分销管道、应用、最终用户划分 - 2024-2030 年全球预测PTA Balloon Catheter Market by Matrerial (Nylon, Polyurethane), Distribution Channel (Offline, Online), Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年PTA球囊导管市场规模为28.2亿美元,预计2024年将达30.1亿美元,2030年将达45.1亿美元,复合年增长率为6.91%。
经皮成形术(PTA)球囊导管是一种主要用于治疗心血管疾病的导管。 PTA 球囊导管的尖端具有可充气的球状结构,用于微创导管治疗。 PTA球囊导管广泛应用于心臟、週边、神经血管等广泛的医疗领域。心血管疾病的增加和人口老化使得医疗机构必须采用 PTA 球囊导管。扩大医疗基础设施以及政府为扩大心血管医疗保健覆盖范围和提高人们对心血管问题的认识所做的努力,正在进一步扩大 PTA 球囊导管的使用。然而,严格的监管标准和核准流程、越来越多的产品案例以及高昂的产品价格是阻碍 PTA 球囊导管装置普及的障碍。此外,这些导管的功能复杂性和技术限制也抑制了PTA球囊导管的发展。然而,如果领先企业在产品和技术创新领域进行投资,则可以避免与 PTA 球囊导管的技术限制相关的挑战。研究和创新的关键领域包括改进导管设计和提高生物相容性。
主要市场统计 | |
---|---|
基准年[2023] | 28.2亿美元 |
预测年份 [2024] | 30.1亿美元 |
预测年份 [2030] | 45.1亿美元 |
复合年增长率(%) | 6.91% |
材质尼龙具有优异的耐腐蚀,广泛应用于PTA球囊导管。
尼龙因其优异的强度、耐磨性和弹性而广泛应用于设备产业。这种合成聚合物具有弹性、重量轻、耐腐蚀、耐磨的特性。尼龙经常被用作医疗设施中的气球材料,因为它能够在薄壁中保持高压。聚氨酯具有优异的弹性、强度、耐磨性和耐化学性,使其可用于短期植入装置。此外,聚氨酯的耐用性使其适用于与其他材料摩擦的器具。由于聚氨酯的疏水性、良好的稳定性以及热和机械相容性,被广泛应用于循环系统生物材料的生产。
分销管道:网路药局的扩张有助于引入线上分销管道
PTA球囊导管的线下经销主要包括医院、药局、诊所。线下管道之所以受到青睐,是因为它们在关键手术期间可以立即使用,可以与医务负责人直接互动以获取产品信息,并且可以满足互联网访问受限的患者的需求。然而,增加的储存和库存成本可能是一个缺点。随着网路药局和线上医疗商店的兴起,线上平台正在取得进展。采用线上分销管道的优势包括宅配的便利性、降低库存成本以及全球扩张的可能性。然而,仿冒品和交付延迟的风险可能会影响普及率,特别是在网路普及较低的农村地区。
应用:由于冠状动脉疾病增加而需要 PTA 球囊导管
冠状动脉疾病(CAD)是一种以冠状动脉硬化和狭窄为特征的疾病,需要放置支架并使用PTA球囊导管来恢復血流。急性心肌梗塞患者通常需要即时进行血管成形术。週边血管疾病(PVD)是一种由血管狭窄或闭塞引起的缓慢进行性的循环系统疾病。 PTA球囊导管在周边血管疾病(PVD)治疗的应用主要涉及扩张週边动脉狭窄的血管。
最终用户专科诊所对 PTA 球囊导管的需求不断增长
向门诊手术的转变使门诊手术中心 (ASC) 成为 PTA 球囊导管的主要最终用户。认识到对非侵入性快速手术的需求,製造商开发了 PTA 球囊导管来解决这一领域的问题。医院和诊所是传统的最终用户,需要多功能、多功能的 PTA 球囊导管。製造商正在迅速产品推出以扩大其导管产品组合,从而显着改善这些环境中的住院和结果。专科诊所,特别是心血管和周边动脉疾病专科诊所,需要创新的、针对疾病的 PTA 球囊导管。
区域洞察
美洲地区医疗保健基础设施的技术进步,加上心血管疾病的迅速增加,增加了在治疗过程中使用 PTA 球囊导管的需求。该地区医疗设备製造商的存在刺激了 PTA 球囊导管的广泛采用。 PTA 球囊导管的使用在欧洲同样重要,趋势表明,由于其成本效益和住院时间缩短,微创手术迅速增加。许多欧洲国家推荐使用PTA球囊导管。此外,欧洲对医疗设备的严格监管环境要求使用经过测试和核准的设备,例如 PTA 球囊导管,正在扩大其在医院、诊所和医疗机构的使用。由中国、日本和印度组成的亚太地区预计 PTA 球囊导管领域将显着成长。这是由于医疗保健基础设施的改善以及对医疗设备研发的日益关注所推动的。此外,中国的大批量生产能力和印度的成本效益製造可能为PTA球囊导管的未来成长提供机会。
FPNV定位矩阵
FPNV定位矩阵对于评估PTA球囊导管市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对 PTA 球囊导管市场供应商的现况进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.PTA球囊导管市场的市场规模和预测是多少?
2.在PTA球囊导管市场预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.PTA球囊导管市场的技术趋势和法规结构是什么?
4.PTA球囊导管市场主要厂商的市场占有率是多少?
5.进入PTA球囊导管市场的合适型态和策略性手段是什么?
[195 Pages Report] The PTA Balloon Catheter Market size was estimated at USD 2.82 billion in 2023 and expected to reach USD 3.01 billion in 2024, at a CAGR 6.91% to reach USD 4.51 billion by 2030.
A percutaneous transluminal angioplasty (PTA) balloon catheter is a type of catheter used primarily in the treatment of cardiovascular diseases. A PTA balloon catheter has an inflatable balloon-like structure at its tip, which is used during a minimally invasive catheterization procedure. PTA balloon catheters find widespread applications in a broad spectrum of medical arenas, such as cardiac, peripheral, and neurovascular procedures. The rising incidences of cardiovascular diseases and a growing geriatric population have necessitated the adoption of PTA balloon catheters in healthcare facilities. Expanding healthcare infrastructure and government initiatives to expand access to cardiovascular healthcare and raise awareness about cardiovascular issues have further expanded the utilization of PTA balloon catheters. However, stringent regulatory norms and approval processes, rising cases of product recalls, and high product pricing pose hurdles to the widespread adoption of PTA balloon catheter devices. Furthermore, the functional complexities and technical limitations of these catheters also impede the growth of PTA balloon catheters. However, investments by major players in areas of product and technology innovation can help circumvent challenges related to the technical limitations of PTA balloon catheters. Key areas of research and innovation include improving catheter design and enhancing biocompatibility.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.82 billion |
Estimated Year [2024] | USD 3.01 billion |
Forecast Year [2030] | USD 4.51 billion |
CAGR (%) | 6.91% |
Material: Widespread adoption of nylon in PTA balloon catheters due to its superior corrosion resistance
Nylon is widely used in the equipment industry due to its superior strength, wear resistance, and flexibility. This synthetic polymer offers elasticity and is lightweight and resistant to corrosion and abrasion. Nylon is often used as a balloon material in medical facilities due to its high-pressure holding capacity in thin-walled sections. Polyurethane is flexible, strong, and resistant to abrasions and chemicals, making it viable for use in short-term implant devices. Additionally, the durability of polyurethane makes it useful for devices that rub against other materials. Due to the hydrophobicity, good stability, thermal and mechanical compatibility of polyurethane, it is widely used in the manufacture of cardiovascular biomaterials.
Distribution channel: Expanding e-pharmacies contributing to the adoption of online distribution channels
Offline distribution of PTA balloon catheters primarily includes hospitals, pharmacies, and clinics. Offline channels are preferred due to the need for immediate availability during critical surgeries, direct interaction with medical representatives for product information, and for patients with limited internet access. However, an increase in storage and inventory costs could prove to be a disadvantage. Online platforms have been gaining traction due to the increase in e-pharmacies and online medical stores. The benefits of adopting online distribution channels include home delivery convenience, reduced inventory costs, and the possibility of global reach. However, the risk of counterfeit products and delayed deliveries may affect its adoption rate, especially in rural areas with lower internet penetration.
Application: Growing incidences of coronary artery disease necessitating the adoption of PTA balloon catheter
Coronary artery disease (CAD), a disease characterized by the hardening or narrowing of coronary arteries, necessitates the use of a PTA balloon catheter for stent placement and restoring blood flow. Patients with acute myocardial infarction often require immediate angioplasty. Peripheral vascular disease (PVD) is a slow and progressive circulation disorder caused by the narrowing or blockage in a blood vessel. The application of a PTA balloon catheter in peripheral vascular disease (PVD) treatment primarily involves expanding narrowed blood vessels in peripheral arteries.
End-user: Widening need for PTA balloon catheters in specialist clinics
Due to the shift towards outpatient procedures, ambulatory surgery centers (ASCs) have become primary end-users of PTA balloon catheters. Recognizing the need for a non-invasive and quick procedural turnaround time, manufacturers have developed a range of PTA balloon catheters catering to this sector. Hospitals or clinics are traditional end-users that require versatile and multifunctional PTA balloon catheters. Manufacturers are rapidly investing in product launches to expand their catheter line, significantly improving inpatient procedures and outcomes in these settings. Specialist clinics, especially those focusing on cardiovascular and peripheral artery diseases, necessitate innovative and disease-specific PTA balloon catheters.
Regional Insights
The technological advancements in healthcare infrastructure in the Americas region coupled with the surging rate of cardiovascular diseases, have necessitated the adoption of PTA balloon catheters for therapeutic procedures. The presence of established medical device manufacturers acts as a stimulant to the burgeoning adoption of PTA balloon catheters in the region. The utilization of PTA balloon catheters is equally significant in Europe, with trends suggesting a surge in minimally invasive surgeries considering their cost-effectiveness and shorter hospital stays. Many European nations have been influential in endorsing the use of PTA balloon catheters. Furthermore, the stringent regulatory landscape of medical devices in Europe mandates the use of tested and approved devices such as PTA balloon catheters, further solidifying their widespread usage across hospitals, clinics, and healthcare settings. The Asia Pacific, comprising China, Japan, and India, is projected to show significant growth in the PTA balloon catheter space. This is due to rising improvements in healthcare infrastructure and an increased focus on research and development in medical devices. Moreover, China's capacity for mass production and India's cost-effective manufacturing could provide future opportunities for the growth of PTA balloon catheters.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the PTA Balloon Catheter Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the PTA Balloon Catheter Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the PTA Balloon Catheter Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accura Medizintechnik GmbH, Andratec GmbH, AV Medical Technologies Ltd., B. Braun SE, Becton, Dickinson and Company, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, BrosMed Medical Co., Ltd, Cardinal Health, Inc., Conic Vascular, Cook Medical Inc., Freudenberg & Co. KG, Infinity Angioplasty Balloon Company, Koninklijke Philips N.V., Leo Medical Co.,Ltd., Medcaptain Medical Technology Co., Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Nordson Corporation, NuMED, Poba Medical, Q3 Medical Devices Limited, QX Medical LLC, Ridgeback Technologies, Simeks Medical, Teleflex Incorporated, and Terumo Medical Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the PTA Balloon Catheter Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the PTA Balloon Catheter Market?
3. What are the technology trends and regulatory frameworks in the PTA Balloon Catheter Market?
4. What is the market share of the leading vendors in the PTA Balloon Catheter Market?
5. Which modes and strategic moves are suitable for entering the PTA Balloon Catheter Market?